Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

For the Neuromodulation Team at Oxford University Hospitals, 2016 has had an electrifying start. The team have been performing dorsal root ganglion (DRG) stimulation since 2013 and were one of the first UK centres to perform the procedure.

Dr Jeff Kramer from St Jude Medical talking about the physiology of DRG stimulation
Dr Jeff Kramer from St Jude Medical talking about the physiology of DRG stimulation

The technique is used to treat chronic, intractable pain and involves the placing of a stimulating electrode over the DRG, a small enlargement of the nerve as it enters the spine. This is done with the patient awake via an epidural puncture and the lead is steered into position under X-ray control.

Tip Lead Delivery System“This treatment is a game-changer and early results suggest that not only do we get more pain relief than traditional spinal cord stimulation in some patient groups, but we are able to treat people with conditions such as complex regional pain syndrome and post-surgical pain such as hernia repair, that we used to struggle to successfully treat” says Mr James Fitzgerald, a Consultant Neurosurgeon from the Nuffield Department of Surgical Sciences and one of the surgeons involved.

The Oxford team have been involved with a variety of clinical research, designed to support the current indications, and to investigate the effect the therapy has on new groups of patients who don’t currently have a treatment option. This has led to the team successfully treating some world first patient indications with the therapy.

The DRG Masterclass was a three-day international course aimed at introducing the American physicians to the technique (prior to FDA approval) and to hone the skills of the UK practitioners. The course involved cadaver sessions where attendees had the chance to practice their skills on human bodies, based at the University of Oxford’s Department of Physiology, Anatomy and Genetics. There were lectures and also a morning of live surgeries performed in the Neurosurgical Theatres at the John Radcliffe Hospital and watched by the participants from a lecture theatre.

The course was supported by St Jude Medical (SJM), manufacturers of the electrodes. Clair Jackson, Therapy Development Manager at SJM, said: “Oxford is one of the leading centres globally for DRG both in terms of research and teaching. Mr Alex Green and Mr James Fitzgerald have convened a highly successful course and we have received excellent feedback from the participants. We would also like to thank the Advanced Nurse Practitioners in the team; Liz Moir, Karen Dawson, Claire Camidge and Rodrigo Ortega Garcia for their expertise in programming the electrodes”.

The image above shows a DRG lead that is inserted into a patient's spine.

Similar stories

Nuffield Department of Surgical Sciences launches new Basics for Medical Education Course

Department Teaching

During 2020, the Nuffield Department of Surgical Sciences (NDS) Education Team launched a new one-day course, Basics for Medical Education Course (BMEC), as an introduction to teaching and education in the workplace.

Government boost for digitisation and AI in pathology services

Awards and appointments Clinical Women

Oxford University Hospitals (OUH) is one of the NHS trusts that will benefit from a £13.5m national funding boost to further enhance cellular pathology services and provide faster and more accurate diagnosis of deadly diseases such as cancer.

QUOD enters partnership with Evotec


Evotec SE, a drug discovery and development solutions company, today announced a partnership agreement with the University of Oxford regarding access to biospecimens from the biobank Quality in Organ Donation (QUOD), an initiative of the Nuffield Department of Surgical Sciences (NDS) at the University of Oxford in close collaboration with the National Health Service Blood and Transplant (NHSBT) organisation in the UK.

How Oxford Medical Sciences is fighting Coronavirus

Clinical Research

Researchers from across the Medical Sciences Division are working hard to combat the COVID-19 crises. With particular strengths in infectious diseases and international health, we are well placed to contribute to better understanding and effectively controlling the epidemic.

NDS professor receives teaching excellence award

Awards and appointments Teaching

The 2019 MSD Teaching Excellence Awards were celebrated in a ceremony at Merton College on Wednesday 23 October.

Professor David Taggart presents results of the VEST III trial

Clinical Research

On Friday 4 October, Professor David Taggart from the Nuffield Department of Surgical Sciences (NDS) presented the results of the VEST III trial at the 2019 European Cardio-Thoracic Surgery annual meeting in Lisbon, Portugal.